Release date: 6/1/2023
Expiration date: 6/1/2024
Activity Overview
The recently enacted Medication Access and Training Expansion (MATE) Act, requires that Drug Enforcement Administration (DEA)-registered health care providers (except those in exclusive veterinary practice) complete training on the treatment and management of opioid or other substance use disorders. This mandated eight (8) hours of education is a one-time requirement and can be fulfilled using one or more continuing education (CE) activities related to opioid and other substance use. Evidence of completed education will be requested after June 27, 2023 whenever a provider applies for a new or renewed DEA registration to be a licensed prescriber of controlled substances.
Target Audience
All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including physicians, nurse practitioners, physician assistants, and dentists.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
Activity 1 – Defining and Managing Pain
- Describe a multidimensional definition of pain that includes the influences originating from three biopsychosocial dimensions.
- Differentiate between acute, subacute, and chronic pain when describing the pain experience.
- Review the rationale supporting the consistent use of validated assessment instruments when assessing pain.
- Describe the recommended decision process to be used when determining whether or not to initiate opioids for pain management
- Describe the types and formulations of opioid drugs that are recommended for use in an outpatient or community setting.
- Outline potential benefits, risks, and harms when prescribing opioids.
- Describe clinical practice recommendations to prevent patient harm when prescribing opioids.
- Recognize the many nonopioid medications and nonpharmacologic interventions that can be used to treat pain.
Activity 2 – Identifying and Managing Patients with Substance Use Disorder (SUD)
- Discuss the use of validated screening tools and the assessment/diagnosis of individuals who screen positive for substance use disorder
- Review strategies for the initiation and management of FDA-approved medications for substance use disorder
- Develop effective patient and family education plans that incorporate how to identify the signs of overdose, patient safety, overdose prevention, and the storage and use of naloxone
Activity 3 – Safe and Effective Pain Management Utilizing Opioid Therapy
- Review the assessment and treatment of patients with acute, subacute, or chronic pain
- Develop effective treatment plans and interprofessional treatment interventions
- List current recommendations and strategies for the management of pain in patients utilizing opioid therapy
- Recognizing signs and symptoms of opioid use disorder (OUD)
Activity 4 – Overcoming Barriers in the Management of Patients with Opioid Use Disorder (OUD)
- Describe treatment planning techniques using patient-centered decision-making and evidence-based communication strategies
- Identify the three types of stigmas and their effect on patients with mental health disorders, substance use disorders (SUD), and in particular patients with opioid use disorder (OUD)
- Discuss legal, ethical, and privacy issues involved in the care of clients with opioid use disorder (OUD)
Criteria for Success
Each activity within the package is accredited and has its own Continuing Education certificate. When packaged together, you can earn up to 8.0 CE credits.
CE activities listed on this page can be taken in any combination to fulfill the eight-hour requirement.
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. If you have questions about this activity, please contact AKH Inc. at [email protected].
CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive up to 8.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.0 AAPA Category 1 CME credits. Approval is valid until 6/1/2024. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.0 contact hour(s) (which includes 3.0 hour(s) of pharmacology).
Dentists
AKH Inc., Advancing Knowledge in Healthcare is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
AKH Inc., Advancing Knowledge in Healthcare designates this activity for 8.0 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Commercial Support
There is no commercial support for this activity.
Faculty – Activities 1 and 2
Mary Kathleen Ebener PhD, RN
Faculty – Activities 3 and 4
Margaret A. Clark, MSc, RN, RRT – NPS, CMPP
Planners and Reviewers
Dorothy Caputo, MA, BSN, RN, VP, Healthcare Continuing Education and Operations
Bernadette Makar, MSN, APRN-BC, NP-C
Disclosures
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
